Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001708135-17-000002
Filing Date
2017-06-01
Accepted
2017-06-01 12:49:53
Documents
1
Effectiveness Date
2017-06-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6452
  Complete submission text file 0001708135-17-000002.txt   7527
Mailing Address 1501 N. CAMPBELL AVE. SARVER HEART CENTER, ROOM 6154 TUCSON AZ 85718
Business Address 1501 N. CAMPBELL AVE. SARVER HEART CENTER, ROOM 6154 TUCSON AZ 85724 9286077410
Avery Therapeutics, Inc. (Filer) CIK: 0001708135 (see all company filings)

EIN.: 464845790 | State of Incorp.: AZ
Type: D | Act: 33 | File No.: 021-287832 | Film No.: 17884077